Publish in this journal
Journal Information
Vol. 47. Issue 2.
Pages 66-72 (January 2011)
Download PDF
More article options
Vol. 47. Issue 2.
Pages 66-72 (January 2011)
Original Article
DOI: 10.1016/S1579-2129(11)70016-7
Full text access
Lung sparing surgery by means of extended broncho-angioplastic (sleeve) lobectomies
Cirugía de preservación pulmonar mediante reconstrucciones broncoangioplásticas extendidas
Abel Gómez-Caroa,??
Corresponding author

Corresponding author.
, Samuel Garcíaa, María José Jiménezb, Purificación Matuteb, J.M. Gimferrera, Laureano Molinsa
a Servicio de Cirugía Torácica, Instituto del Tórax, Hospital Clínico, Universidad de Barcelona (UB), Barcelona, Spain
b Servicio de Anestesia y Reanimación, Hospital Clínico y Provincial de Barcelona, Universidad de Barcelona, Barcelona, Spain
Article information
Download PDF

To determine the morbidity, mortality and survival of sleeve lobectomy procedures extended to more than one lobe compared with bronchoplasty.

Patients and methods

Between September 2005 and May 2010, a total of 535 patients diagnosed with bronchogenic carcinoma who fulfilled the criteria of clinical, oncological and functional operability were treated in our unit. Central tumors (n=95) that were unresectable using simple lobectomy were scheduled for sleeve lobectomy techniques or, if not possible, pneumonectomy.


A total of 58 (11%) procedures were performed: 46 simple bronchoplastic lobectomies (SBL) and 12 extended sleeve lobectomies (ESL). In the SBL group, there were 32 bronchial (70%), 7 vascular (15%) and 7 bronchovascular (15%) reconstructions. In the ESL group, 8 (66.7%) were bronchial and 4 (33.3%) were bronchovascular reconstructions. The most frequent type of resection was the right upper lobe (RUL)+segment 6 in five (41%) cases, followed by RUL+middle lobe. There were 2 (3%) deaths in the SBL group. Morbidity was 34% in the SBL and 33% in the ESL group (P>0.05). Fifteen patients received neoadjuvant chemoradiotherapy for histologically-confirmed cN2; the number of complications, however, was not significantly higher. No risk factors were detected in any variable studied that would affect ESL compared to the SBL group (P>0.05). The patients in both groups with a higher morbidity were pN1, located in the left upper lobe and associated with vascular reconstruction (P<0.05). The overall five-year survival was 61.6%; SBL (61%) and ESL (68.9%) with no differences between groups (P>0.05).


ESL are technically more demanding procedures, but they do not increase morbidity or mortality compared to simple bronchoplasty, and have similar survival.

Sleeve lobectomy
Lung cancer
Lung Preservation

Determinar la morbimortalidad y supervivencia de los procedimientos broncoangioplásticos extendidos a más de un lóbulo en comparación con las técnicas broncoangioplásticas simples.

Pacientes y métodos

Entre septiembre de 2005 y mayo de 2010, 535 pacientes diagnosticados de carcinoma broncogénico que cumplían criterios de operabilidad clínica, oncológica y funcional fueron tratados en nuestra unidad. Los tumores centrales(n=95) no resecables mediante lobectomía simple fueron programados para técnicas broncoangioplásticas y en caso de imposibilidad, neumonectomía.


Se realizaron 58 (11%) procedimientos, 46 lobectomías broncoangioplásticas simples (LBS) y 12 extendidas (LBE). En el grupo de LBS (bronquiales 32 [70%], reconstrucción broncovascular 7 [15%] y vascular sola 7 [15%]). En el grupo de LBE, 8 (66,7%) fueron reconstrucciones bronquiales y 4 (33,3%) broncovasculares. El tipo de resección más frecuente es el lóbulo superior derecho (LSD)+segmento 6 en 5 (41%) casos, seguido del LSD+lóbulo medio. La mortalidad fue de 2 (3%) casos en el grupo LBS. La morbilidad ocurrió en el 34% LSB y en el 33% LBE (p>0,05). Quince pacientes recibieron tratamiento quimiorradioterápico neoadjuvante, por cN2 confirmado histológicamente, sin embargo no se detectó mayor número de complicaciones significativamente (p>0,05). No se detectaron factores de riesgo respecto a ninguna variable estudiada que afectaran a las LBE respecto a las LBS (p>0,05). En ambos grupos, los pacientes con mayor morbilidad fueron pN1, localización en lóbulo superior izquierdo y con reconstrucción vascular asociada (p<0,05). La supervivencia global a los 5 años fue 61,6% LBS (61%) y LBE (68,9%) sin diferencia entre ambos grupos (p>0,05).


Las LBE son procedimientos técnicamente más demandantes pero no aumentan la morbimortalidad respecto a las técnicas broncoangioplásticas simples con una supervivencia similar.

Palabras clave:
Cáncer de pulmón
Preservación pulmonar
Full text is only aviable in PDF
G.E. Darling, A. Abdurahman, Q.L. Yi, M. Johnston, T.K. Waddell, A. Pierre, et al.
Risk of a right pneumonectomy: role of bronchopleural fistula.
Ann Thorac Surg, 79 (2005), pp. 433-437
A. López-Encuentra, R. García-Lujan, J.J. Rivas, J. Rodríguez-Rodríguez, J. Torres-Lanza, G. Varela-Simo.
Comparison between clinical and pathologic staging in 2,994 cases of lung cancer.
Ann Thorac Surg, 79 (2005), pp. 974-979
J. Martin, R.J. Ginsberg, A. Abolhoda, M.S. Bains, R.J. Downey, R.J. Korst, et al.
Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy.
The Annals of Thoracic Surgery, 72 (2001), pp. 1149-1154
J.B. Kim, S.W. Lee, S.I. Park, Y.H. Kim, D.K. Kim.
Risk factor análisis for postoperative Acute respiratory distress syndrome and early mortality alter pneumonectomy: The predictive value of preoperative lung perfusion distribution.
J Thorac Cardiovasc Surg, 140 (2010), pp. 26-33
B. Balduyck, J. Hendriks, P. Lauwers, P. Van Schil.
Quality of life after lung cancer surgery: a prospective pilot study comparing bronchial sleeve lobectomy with pneumonectomy.
J Thorac Oncol, 3 (2008), pp. 604-608
M.J. Schuchert, B.L. Pettiford, J.D. Luketich, R.J. Landreneau.
Parenchymal-sparing resections: why, when, and how.
Thorac Surg Clin, 18 (2008), pp. 93-105
J. Deslauriers, J. Gregoire, L.F. Jacques, M. Piraux, L. Guojin, Y. Lacasse.
Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences.
Ann Thorac Surg, 77 (2004), pp. 1152-1156
F. Rea, G. Marulli, M. Schiavon, A. Zuin, A.M. Hamad, G. Rizzardi, et al.
A quarter of a century experience with sleeve lobectomy for non-small cell lung cancer.
Eur J Cardiothorac Surg, 34 (2008), pp. 488-492
E.A. Rendina, F. Venuta, T. de Giacomo, M. Rossi, G.F. Coloni.
Parenchymal sparing operations for bronchogenic carcinoma.
Surg Clin North Am, 82 (2002), pp. 589-609
K. Yamamoto, Y. Miyamoto, A. Ohsumi, F. Kojima, N. Imanishi, K. Matsuoka, et al.
Sleeve lung resection for lung cancer: analysis according to the type of procedure.
J Thorac Cardiovasc Surg, 136 (2008), pp. 1349-1356
M. Chida, M. Minowa, S. Miyoshi, T. Kondo.
Extended sleeve lobectomy for locally advanced lung cancer.
Ann Thorac Surg, 87 (2009), pp. 900-905
M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, H. Matsuoka, S. Satake, et al.
Extended sleeve lobectomy for lung cancer: The avoidance of pneumonectomy.
The Journal of Thoracic and Cardiovascular Surgery, 118 (1999), pp. 710-714
P. De Leyn, D. Lardinois, P.E. Van Schil, R. Rami-Porta, B. Passlick, M. Zielinski, et al.
ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer.
Eur J Cardiothorac Surg, 32 (2007), pp. 1-8
A. Brunelli, A. Charloux, C.T. Bolliger, G. Rocco, J.-P. Sculier, G. Varela, et al.
The European Respiratory Society and European Society of Thoracic Surgeons clinical guidelines for evaluating fitness for radical treatment (surgery and chemoradiotherapy) in patients with lung cancer.
European Journal of Cardio-Thoracic Surgery, 36 (2009), pp. 181-184
A. Gómez-Caro, S. García, N. Reguart, P. Arguis, M. Sánchez, J.M. Gimferrer, et al.
Incidence of occult mediastinal node involvement in CN0 non-small-cell lung cancer patients after negative uptake of positron emission tomography/computer tomography scan.
Eur J Cardiothorac Surg, 37 (2010), pp. 1167-1168
Staging Manual in thoracic Oncology. International Association for the study of lung cancer Editorial RX Press 2009.
E. Fadel, B. Yildizeli, A.R. Chapelier, I. Dicenta, S. Mussot, P.G. Dartevelle.
Sleeve lobectomy for bronchogenic cancers: factors affecting survival.
Ann Thorac Surg, 74 (2002), pp. 851-888
J. Rubins, M. Unger, G.L. Colice.
Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition).
Chest, 132 (2007), pp. 355S-367S
T. Schulte, B. Schniewind, P. Dohrmann, T. Kuchler, R. Kurdow.
The extent of lung parenchyma resection significantly impacts long-term quality of life in patients with Non Small Cell Lung Cancer.
Chest, 135 (2009), pp. 322-329
C. Ludwig, E. Stoelben, M. Olschewski, J. Hasse.
Comparison of morbidity, 30-day mortality, and long-term survival after pneumonectomy and sleeve lobectomy for non-small cell lung carcinoma.
Ann Thorac Surg, 79 (2005), pp. 968-973
C.A. Angeletti, A. Janni, P. Macchiarini, F. Ricagna, G. Pistelli.
Functional results of bronchial sleeve lobectomy.
Eur J Cardiothorac Surg, 5 (1991), pp. 410-413
J. Schirren, S. Bolukbas, T. Bergmann, A. Fisseler-Eckhoff, S. Trainer, S. Beqiri.
Prospective study on perioperative risks and functional results in bronchial and bronchovascular sleeve resections.
Thorac Cardiovasc Surg, 57 (2009), pp. 35-41
A. López-Encuentra, J. Astudillo, J. Cerezal, F. González-Aragoneses, N. Novoa, A. Sánchez-Palencia.
Prognostic value of chronic obstructive pulmonary disease in 2994 cases of lung cancer.
Eur J Cardiothorac Surg, 27 (2005), pp. 8-13
A. López-Encuentra, F. Pozo-Rodríguez, P. Martín-Escribano, J.L. Martín de Nicolas, M.J. Díaz de Atauri, J.S. Palomera, et al.
Surgical lung cancer: Risk operative analysis.
Lung Cancer, 44 (2004), pp. 327-337
S. Bolukbas, T. Bergmann, A. Fisseler-Eckhoff, J. Schirren.
Short- and longterm outcome of sleeve resections in the elderly.
Eur J Cardiothorac Surg, 37 (2010), pp. 30-35
J. Deslauriers, F. Tronc, J. Gregoire.
History and current status of bronchoplastic surgery for lung cancer.
Gen Thorac Cardiovasc Surg, 57 (2009), pp. 3-9
Y.T. Kim, C.H. Kang, S.W. Sung, J.H. Kim.
Local control of disease related to lymph node involvement in non-small cell lung cancer after sleeve lobectomy compared with pneumonectomy.
Ann Thorac Surg, 79 (2005), pp. 1153-1161
J.B. Johnston, P.H. Jones.
The treatment of bronchial carcinoma by lobectomy and sleeve resection of the main bronchus.
Thorax, 14 (1959), pp. 48-54
C. Ludwig, R. Riedel, J. Schnell, E. Stoelben.
Inhalation with Tobramycin toimprove healing of tracheobronchial reconstruction.
Eur J Cardiothorac Surg, 35 (2009), pp. 797-800
A. Gomez-Caro.
Broncho-angioplasty surgery in the treatment of lung cancer.
Arch Bronconeumol, 45 (2009), pp. 531-532
A. Gómez-Caro, E. Martínez, A. Rodríguez, D. Sánchez, J. Martorell, J.M. Gimferrer, et al.
Cryopreserved arterial allograft reconstruction after excision of thoracic malignancies.
Ann Thorac Surg, 86 (2008), pp. 1753-1761
F. Jiang, L. Xu, F.L. Yuan, J.F. Huang, X.X. Lu.
Lung autotransplantation technique in the treatment for central lung cancer of upper lobe.
J Thorac Oncol, 3 (2008), pp. 609-611
Copyright © 2011. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología (English Edition)

Subscribe to our newsletter

Article options
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?